FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Osamu Ogawa

Research Profile

Disorders

Physiology

Concepts & Ideas

Procedures

Geographic Areas

Japan

Genes & Molecular Sequences

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Zhiyong Ma; Norihiko Tsuchiya; Takeshi Yuasa; Mingguo Huang; Takashi Obara; Shintaro Narita; Yohei Horikawa; Hiroshi Tsuruta; Mitsuru Saito; Shigeru Satoh; Osamu Ogawa; Tomonori Habuchi
Clinical significance of polymorphism and expression of chromogranin a and endothelin-1 in prostate cancer.
Norihiko Tsuchiya; Shintaro Narita; Teruaki Kumazawa; Takamitsu Inoue; Zhiyong Ma; Hiroshi Tsuruta; Mitsuru Saito; Yohei Horikawa; Takeshi Yuasa; Shigeru Satoh; Osamu Ogawa; Tomonori Habuchi
Clinical significance of a single nucleotide polymorphism and allelic imbalance of matrix metalloproteinase-1 promoter region in prostate cancer.
Zhiyong Ma; Norihiko Tsuchiya; Takeshi Yuasa; Takamitsu Inoue; Teruaki Kumazawa; Shintaro Narita; Yohei Horikawa; Hiroshi Tsuruta; Takashi Obara; Mitsuru Saito; Shigeru Satoh; Osamu Ogawa; Tomonori Habuchi
Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Osamu Ogawa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Zhiyong Ma; Norihiko Tsuchiya; Takeshi Yuasa; Mingguo Huang; Takashi Obara; Shintaro Narita; Yohei Horikawa; Hiroshi Tsuruta; Mitsuru Saito; Shigeru Satoh; Osamu Ogawa; Tomonori Habuchi
Clinical significance of polymorphism and expression of chromogranin a and endothelin-1 in prostate cancer.
The Journal of urology 2010;184(3):1182-8.
2009: Norihiko Tsuchiya; Shintaro Narita; Teruaki Kumazawa; Takamitsu Inoue; Zhiyong Ma; Hiroshi Tsuruta; Mitsuru Saito; Yohei Horikawa; Takeshi Yuasa; Shigeru Satoh; Osamu Ogawa; Tomonori Habuchi
Clinical significance of a single nucleotide polymorphism and allelic imbalance of matrix metalloproteinase-1 promoter region in prostate cancer.
Oncology reports 2009;22(3):493-9.
2008: Zhiyong Ma; Norihiko Tsuchiya; Takeshi Yuasa; Takamitsu Inoue; Teruaki Kumazawa; Shintaro Narita; Yohei Horikawa; Hiroshi Tsuruta; Takashi Obara; Mitsuru Saito; Shigeru Satoh; Osamu Ogawa; Tomonori Habuchi
Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population.
International journal of cancer. Journal international du cancer 2008;123(11):2574-9.
2008: Yohei Horikawa; Junichi Nadaoka; Mitsuru Saito; Teruaki Kumazawa; Takamitu Inoue; Takeshi Yuasa; Norihiko Tsuchiya; Hiroyuki Nishiyama; Osamu Ogawa; Tomonori Habuchi
Clinical implications of the MDM2 SNP309 and p53 Arg72Pro polymorphisms in transitional cell carcinoma of the bladder.
Oncology reports 2008;20(1):49-55.
2008: Junichi Nadaoka; Yohei Horikawa; Mitsuru Saito; Teruaki Kumazawa; Takamitsu Inoue; Shintaro Narita; Takeshi Yuasa; Shigeru Satoh; Hiroyuki Nishiyama; Osamu Ogawa; Norihiko Tsuchiya; Tomonori Habuchi
Prognostic significance of HIF-1 alpha polymorphisms in transitional cell carcinoma of the bladder.
International journal of cancer. Journal international du cancer 2008;122(6):1297-302.
2008: Naofumi Narita; Takeshi Yuasa; Norihiko Tsuchiya; Teruaki Kumazawa; Shintaro Narita; Takamitsu Inoue; Zhiyong Ma; Mitsuru Saito; Yohei Horikawa; Shigeru Satoh; Osamu Ogawa; Tomonori Habuchi
A genetic polymorphism of the osteoprotegerin gene is associated with an increased risk of advanced prostate cancer.
BMC cancer 2008;8():224.
2007: Hisami Fukuda; Norihiko Tsuchiya; Shintaro Narita; Teruaki Kumazawa; Yohei Horikawa; Takamitsu Inoue; Mitsuru Saito; Takeshi Yuasa; Shinobu Matsuura; Shigeru Satoh; Osamu Ogawa; Tomonori Habuchi
Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer.
Oncology reports 2007;18(5):1155-63.
2006: Takamitsu Inoue; Takuo Ito; Shintaro Narita; Yohei Horikawa; Norihiko Tsuchiya; Hideaki Kakinuma; Mutsuki Mishina; Eijiro Nakamura; Tetsuro Kato; Osamu Ogawa; Tomonori Habuchi
Association of BCL10 germ line polymorphisms on chromosome 1p with advanced stage testicular germ cell tumor patients.
Cancer letters 2006;240(1):41-7.
2006: Norihiko Tsuchiya; Lizhong Wang; Hiroyoshi Suzuki; Takehiko Segawa; Hisami Fukuda; Shintaro Narita; Masaki Shimbo; Toshiyuki Kamoto; Kenji Mitsumori; Tomohiko Ichikawa; Osamu Ogawa; Akira Nakamura; Tomonori Habuchi
Impact of IGF-I and CYP19 gene polymorphisms on the survival of patients with metastatic prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(13):1982-9.
2006: Norihiko Tsuchiya; Mutsuki Mishina; Shintaro Narita; Teruaki Kumazawa; Takamitsu Inoue; Yohei Horikawa; Hideaki Kakinuma; Takeshi Yuasa; Shinobu Matsuura; Shigeru Satoh; Osamu Ogawa; Tomonori Habuchi
Association of XRCC1 gene polymorphisms with the susceptibility and chromosomal aberration of testicular germ cell tumors.
International journal of oncology 2006;28(5):1217-23.
2005: Li Zhenhua; Norihiko Tsuchiya; Shintaro Narita; Takamitsu Inoue; Yohei Horikawa; Hideaki Kakinuma; Tetsuro Kato; Osamu Ogawa; Tomonori Habuchi
CYP3A5 gene polymorphism and risk of prostate cancer in a Japanese population.
Cancer letters 2005;225(2):237-43.
2005: Norihiko Tsuchiya; Lizhong Wang; Yohei Horikawa; Takamitsu Inoue; Hideaki Kakinuma; Shinobu Matsuura; Kazunari Sato; Osamu Ogawa; Tetsuro Kato; Tomonori Habuchi
CA repeat polymorphism in the insulin-like growth factor-I gene is associated with increased risk of prostate cancer and benign prostatic hyperplasia.
International journal of oncology 2005;26(1):225-31.
2004: Shintaro Narita; Norihiko Tsuchiya; Lizhong Wang; Shinobu Matsuura; Chikara Ohyama; Shigeru Satoh; Kazunari Sato; Osamu Ogawa; Tomonori Habuchi; Tetsuro Kato
Association of lipoprotein lipase gene polymorphism with risk of prostate cancer in a Japanese population.
International journal of cancer. Journal international du cancer 2004;112(5):872-6.
2004: Jiangang Yu; Tomonori Habuchi; Norihiko Tsuchiya; Eijiro Nakamura; Hideaki Kakinuma; Yohei Horikawa; Takamitsu Inoue; Osamu Ogawa; Tetsuro Kato
Association of the cyclin D1 gene G870A polymorphism with susceptibility to sporadic renal cell carcinoma.
The Journal of urology 2004;172(6 Pt 1):2410-3.
2004: Yasushi Ichimura; Tomonori Habuchi; Norihiko Tsuchiya; Lizhong Wang; Chikara Oyama; Kazunari Sato; Hiroyuki Nishiyama; Osamu Ogawa; Tetsuro Kato
Increased risk of bladder cancer associated with a glutathione peroxidase 1 codon 198 variant.
The Journal of urology 2004;172(2):728-32.
2004: Teruaki Kumazawa; Norihiko Tsuchiya; Lizhong Wang; Kazunari Sato; Toshiyuki Kamoto; Osamu Ogawa; Akira Nakamura; Tetsuro Kato; Tomonori Habuchi
Microsatellite polymorphism of steroid hormone synthesis gene CYP11A1 is associated with advanced prostate cancer.
International journal of cancer. Journal international du cancer 2004;110(1):140-4.
2004: Zhenhua Li; Tomonori Habuchi; Norihiko Tsuchiya; Kenji Mitsumori; Lizhong Wang; Chikara Ohyama; Kazunari Sato; Toshiyuki Kamoto; Osamu Ogawa; Tetsuro Kato
Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10.
Carcinogenesis 2004;25(2):237-40.
2003: Lizhong Wang; Kazunari Sato; Norihiko Tsuchiya; Jian-Gang Yu; Chikara Ohyama; Shigeru Satoh; Tomonori Habuchi; Osamu Ogawa; Tetsuro Kato
Polymorphisms in prostate-specific antigen (PSA) gene, risk of prostate cancer, and serum PSA levels in Japanese population.
Cancer letters 2003;202(1):53-9.
2003: Lizhong Wang; Tomonori Habuchi; Norihiko Tsuchiya; Kenji Mitsumori; Chikara Ohyama; Kazunari Sato; Hidehumi Kinoshita; Toshiyuki Kamoto; Akira Nakamura; Osamu Ogawa; Tetsuro Kato
Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer.
Cancer research 2003;63(15):4407-11.
2003: Zhenhua Li; Tomonori Habuchi; Kenji Mitsumori; Toshiyuki Kamoto; Hidefumi Kinoshitu; Takehiko Segawa; Osamu Ogawa; Tetsuro Kato
Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population.
The Journal of urology 2003;169(6):2378-81.
2003: Lizhong Wang; Tomonori Habuchi; Kenji Mitsumori; Zhenhua Li; Toshiyuki Kamoto; Hidefumi Kinoshita; Norihiko Tsuchiya; Kazunari Sato; Chikara Ohyama; Akira Nakamura; Osamu Ogawa; Tetsuro Kato
Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism.
International journal of cancer. Journal international du cancer 2003;103(1):116-20.
2002: Akihiko Abe; Kazunari Sato; Tomonori Habuchi; Lizhong Wang; Zhenhua Li; Norihiko Tsuchiya; Chikara Ohyama; Shigeru Satoh; Osamu Ogawa; Tetsuro Kato
Single nucleotide polymorphisms in the 3' untranslated region of vascular endothelial growth factor gene in Japanese population with or without renal cell carcinoma.
The Tohoku journal of experimental medicine 2002;198(3):181-90.
2002: Lizhong Wang; Tomonori Habuchi; Takeshi Takahashi; Toshiyuki Kamoto; Tao Zuo; Kenji Mitsumori; Norihiko Tsuchiya; Kazunari Sato; Osamu Ogawa; Tetsuro Kato
No association between HER-2 gene polymorphism at codon 655 and a risk of bladder cancer.
International journal of cancer. Journal international du cancer 2002;97(6):787-90.
2002: Lizhong Wang; Tomonori Habuchi; Takeshi Takahashi; Kenji Mitsumori; Toshiyuki Kamoto; Yoshiyuki Kakehi; Hideaki Kakinuma; Kazunari Sato; Akira Nakamura; Osamu Ogawa; Tetsuro Kato
Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.
Carcinogenesis 2002;23(2):257-64.
2001: Norihiko Tsuchiya; Kozo Sato; T Akao; H Kakinuma; R Sasaki; N Shimoda; Shigeru Satoh; Tomonori Habuchi; Osamu Ogawa; Tetsuro Kato
Quantitative analysis of gene expressions of vascular endothelial growth factor-related factors and their receptors in renal cell carcinoma.
The Tohoku journal of experimental medicine 2001;195(2):101-13.
2001: Hideaki Kakinuma; Tomonori Habuchi; T Ito; Mutsuki Mishina; K Sato; Shigeru Satoh; Toshiya Akao; Osamu Ogawa; Tetsuro Kato
BCL10 is not a major target for frequent loss of 1p in testicular germ cell tumors.
Cancer genetics and cytogenetics 2001;126(2):134-8.
2000: Tomonori Habuchi; Z Liqing; Toshio Suzuki; R Sasaki; Norihiko Tsuchiya; H Tachiki; N Shimoda; Shigeru Satoh; Kazunari Sato; Y Kakehi; Toshiyuki Kamoto; Osamu Ogawa; Tetsuro Kato
Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect.
Cancer research 2000;60(20):5710-3.
2000: Tomonori Habuchi; Toshio Suzuki; R Sasaki; Lizhong Wang; Kazunari Sato; Shigeru Satoh; T Akao; Norihiko Tsuchiya; N Shimoda; Y Wada; A Koizumi; J Chihara; Osamu Ogawa; Tetsuro Kato
Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population.
Cancer research 2000;60(2):305-8.
2000: Norihiko Tsuchiya; Kazunari Sato; Naotake Shimoda; Shigeru Satoh; Tomonori Habuchi; Osamu Ogawa; Tetsuro Kato
An accessory spleen mimicking a nonfunctional adrenal tumor: a potential pitfall in the diagnosis of a left adrenal tumor.
Urologia internationalis 2000;65(4):226-8.
1999: Osamu Ogawa; M Iinuma; K Sato; R Sasaki; Naotake Shimoda; S Satoh; T Kato
Circulating prostate-specific antigen mRNA during radical prostatectomy in patients with localized prostate cancer: with special reference to neoadjuvant hormonal therapy.
Urological research 1999;27(4):291-6.
1999: Ryo Otomo; Naotake Shimoda; Shigeru Satoh; Kazunari Sato; Osamu Ogawa; Tetsuro Kato
[The role of ATP-receptor in controlling the urinary bladder and urethral function in rats].
Nihon Hinyōkika Gakkai zasshi. The japanese journal of urology 1999;90(7):681-7.
1999: T Ishida; Naotake Shimoda; Kazunari Sato; Osamu Ogawa; O Nishizawa; Tetsuro Kato
[Effects of ischemia on voiding function and nerve growth factor of the rat urinary bladder].
Nihon Hinyōkika Gakkai zasshi. The japanese journal of urology 1999;90(5):564-71.
1999: Masahiro Iinuma; Kazunari Sato; Osamu Ogawa; R Sasaki; Tetsuro Kato
[Detection of prostate-specific antigen mRNA in preoperative peripheral blood of patients with prostate cancer: relationship to pathological parameters of the surgical specimens].
Nihon Hinyōkika Gakkai zasshi. The japanese journal of urology 1999;90(5):548-56.
1999: T Suzuki; Norihiko Tsuchiya; Ryo Otomo; Hideaki Kakinuma; Shigeru Satoh; Kazunari Sato; Osamu Ogawa; Tetsuro Kato
Primary tumor of the ureteral stump following a nephrectomy for renal cell carcinoma.
International journal of urology : official journal of the Japanese Urological Association 1999;6(1):41-3.
1998: N Shimoda; Kazunari Sato; Shigeru Satoh; Osamu Ogawa; S Ito; Tetsuro Kato
Atypical true hermaphroditism with a mosaic 45,X/46,X,dic(Y) (q11.2) karyotype.
The Journal of urology 1998;160(4):1434-5.
1998: Osamu Ogawa; S Egawa; Yoichi Arai; K Tobisu; O Yoshida; Tetsuro Kato
Preoperative predictors for organ-confined disease in Japanese patients with stage T1c prostate cancer.
International journal of urology : official journal of the Japanese Urological Association 1998;5(5):454-8.
1998: Kozo Sato; R Sasaki; Y Ogura; N Shimoda; H Togashi; K Terada; Toshihiro Sugiyama; H Kakinuma; Osamu Ogawa; Tetsuro Kato
Expression of vascular endothelial growth factor gene and its receptor (flt-1) gene in urinary bladder cancer.
The Tohoku journal of experimental medicine 1998;185(3):173-84.